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contraindications to use midazolam or fentanyl, 
diminished communication capacity, and cogni-
tive disorders. The study was approved by the Eth-
ics Committee at Jagiellonian University, Kraków, 
Poland.
In all patients, topical anesthesia was used ac-
cording to current guidelines.4 Most patients re-
ceived a bolus of midazolam (2.5 mg) and fentan-
yl (0.05 mg) before the examination. If necessary, 
both medications were titrated in incremental 
doses during FB to achieve adequate analgoseda-
tion. The initial dose of fentanyl was not adminis-
tered in 23 patients for one of the following rea-
sons: exacerbation of chronic obstructive pulmo-
nary disease, respiratory failure, or advanced age 
with several comorbidities. A bronchofiberoscope 
was introduced through a mouthpiece 3 minutes 
after drug administration. During the whole pro-
cedure, vital parameters were monitored including 
oxygen saturation, blood pressure, and electrogra-
phy; adverse events were also recorded. The level 
of patient sedation was continuously assessed ac-
cording to the Ramsey sedation scale.6 The study 
personnel were trained in acute life support and 
study nurses had specialization in anesthesia and 
intensive care. During the whole procedure, the 
patient’s spontaneous ventilation was sustained 
with oxygen administered through a nasal can-
nula if needed (in 282 patients, approximately 
3.5 l/min of O2). Monitoring was continued fol-
lowing FB until complete recovery from sedation 
was observed. If needed, patients were adminis-
tered antagonists—flumazenil and naloxone—to 
reverse drug reaction. Immediate anesthesiolo-
gist support was available at all time during the 
study in case of need.
A statistical analysis was performed using the 
Statistica software (version 10.0; StatSoft, Inc., 
Introduction Flexible bronchoscopy (FB) is one 
of the most commonly used diagnostic and thera-
peutic tools in current respiratory medicine.1 It is 
an invasive method that is unpleasant for the pa-
tient and is preferably performed under analgose-
dation.2 According to several studies, relieving the 
patient’s anxiety during the endoscopic procedure 
shortens the time of the procedure and prevents 
adverse events.3 There are no exact guidelines on 
how to perform analgosedation; however, most 
authors agree that using only topical anesthesia 
is insufficient and suggest using moderate seda-
tion, previously known as conscious sedation.4 
This approach enables the medical personnel to 
stay in verbal contact with the patient and, at 
the same time, to relieve unpleasant symptoms. 
In several countries, mainly in Europe, moder-
ate sedation in endoscopic procedures is restrict-
ed only to anesthetists despite several reports on 
the safety and cost-effectiveness of sedation ap-
plied by nonanesthesiologists.5-7
Between the years 2013 and 2014, we per-
formed a prospective observational study that 
aimed to assess factors that influence anxiety 
and satisfaction in patients undergoing FB under 
analgosedation.8 In this brief communication, we 
would like to present data on the safety of mod-
erate sedation applied by nonanesthesiologists.
Patients and methods After obtaining written 
consent to participate in the study, we enrolled 
463 consecutive patients undergoing FB at the 
Department of Pulmonology of the University 
Hospital in Krakow, Poland. The exclusion crite-
ria were as follows: respiratory failure (defined 
as hemoglobin oxygen saturation [SpO2] below 
90% despite oxygen therapy or need for more 
than 50% of oxygen in a respiratory mixture), 
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most common sedation/analgesic drugs are ben-
zodiazepines and opioids. Some researchers have 
also suggested that the use of propofol instead of 
benzodiazepines is preferable because of a more 
rapid patient’s recovery.9 These drugs proved to 
be safe in several studies used by nonanesthesi-
ologists,5-7 and are recommended by most gas-
troenterology and respiratory societies to use for 
moderate sedation in various endoscopic proce-
dures.4,10,11 Despite this, anesthesiology societies 
have raised several safety concerns, especially re-
garding the use of propofol12 by nonanesthesiol-
ogists, and the use of moderate sedation has not 
been legally approved in many countries (includ-
ing Poland), being restricted solely to anesthesi-
ologists. One of the main concerns of  is the an-
esthesiologists concept of the continuum of se-
dation, which means that the patient’s sedation 
status can change anytime during anesthesia and 
advance to deeper anesthesia, which requires me-
chanical ventilation support.10 Physicians dealing 
with moderate sedation should be aware of that 
fact and know how to react immediately. Several 
countries have implemented training programs 
for nonanesthesiologists on how to safely per-
form the procedure.13,14
In the current study, we reported our findings 
on the safety of moderate anesthesia used during 
FB by nonanesthesiologists. Even though most 
of the patients requiring FB are in severe general 
condition, the procedure proved to be safe, with 
a relatively few complications that were imme-
diately reversed.
In our study, we used analgosedation with mid-
azolam and fentanyl. These drugs have a relative-
ly safe profile, and if titrated in small incremental 
Tulsa, Oklahoma, United States). Data were ex-
pressed as mean ± standard deviation or as the 
absolute number with percentage distribution. 
The χ2 test was used to make comparisons be-
tween the groups (with Yates correction if appli-
cable); P values of less than 0.05 were considered 
statistically significant.
Results The basic characteristics of the patients 
and data concerning the procedure, including 
drug dosing and adverse reactions, are present-
ed in TABLE 1. When adverse reactions were ana-
lyzed according to sex, decreased SpO2 was ob-
served more frequently in women than in men 
(17.7% vs 10.6%; P = 0.03). In procedures lasting 
longer than 30 minutes (n = 58), antagonists were 
required more often than in shorter procedures 
(10.3% vs 4.2%; P = 0.04). Patients who received 
doses of midazolam higher than 5 mg (n = 50) also 
needed reversal drugs more often than patients 
who received lower doses of midazolam (16% vs 
3.3%; P = 0.008). No difference was observed in 
adverse reactions or drug dosing according to age. 
None of the patients died or required intubation 
with mechanical ventilation.
Discussion There is an ongoing discussion on 
the use of analgosedation for short-lasting endo-
scopic procedures such as FB by nonanesthesiol-
ogists. FB is most commonly performed by chest 
physicians under moderate “conscious” anesthe-
sia. Moderate anesthesia is defined as sedation 
during which patients stay in verbal contact with 
medical personnel (sometimes with mild stimu-
lation) and do not require additional interven-
tions to maintain spontaneous ventilation.7 The 
TABLE 1 Complications during flexible bronchoscopy under moderate analgosedation with main demographic 
characteristics of the study population (n = 463)
Parameter Value
age, y 62 ±14.03
sex, male/female 237 (51.19) / 226 (48.81)
duration of the procedure, min 21.78 ±10.22
initial midazolam bolus, mg (n = 463) 2.54 ±0.58
additional midazolam dose, mg (n = 238) 2.75 ±1.17
total midazolam dose, mg 3.95 ±1.72
initial fentanyl bolus, mg (n = 440) 0.051 ±0.01
additional fentanyl dose, mg (n = 176) 0.058 ±0.02
total fentanyl dose, mg 0.07 ±0.04
need for antagonists 23 (4.97)
dose of naloxone, mg (n = 1) 0.4
dose of flumazenil, mg (n = 23) 0.37 ±0.14
hypoxia: ↓SpO2 <90% for >30 s 65 (14.04)
hypoventilation/apnea 7 (1.51)
tachycardia >100 bpm 114 (24.62)
bradycardia <60 bpm 10 (2.16)
BP <90/60 mmHg 3 (0.68)
Data are expressed as mean ± standard deviation or as the number (percentage) of patients.  
Abbreviations: BP, blood pressure; n, number of patients; SpO2, hemoglobin oxygen saturation
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doses and adjusted for comorbidities, age, and 
other factors, they rarely cause complications. 
Nevertheless, it has to be emphasized that prop-
er monitoring of patients and the presence of ex-
perienced personnel are absolutely mandatory to 
perform the procedure. Medical personnel should 
be familiar with the use of antagonists and rever-
sal procedures in case of emergency. The most se-
vere complications due to oversedation are respi-
ratory depression (hypoventilation/apnea) and 
cardiovascular depression (especially bradycar-
dia). These complications occurred in a few pa-
tients during the study period and were imme-
diately reversed.
In conclusion, FB can be safely performed un-
der moderate anesthesia by nonanesthesiolo-
gists. With the widespread use of endoscopic tech-
niques, there is a strong need for discussion be-
tween internal medicine and anesthesiology so-
cieties with the aim to develop safety protocols 
and training programs in moderate sedation in 
Poland. Additionally, there is a need to legally ap-
prove moderate sedation for use by trained phy-
sicians other than anesthesiologists.
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